Literature DB >> 31884280

Health effects of PM2.5 sources on children's allergic and respiratory symptoms in Fukuoka, Japan.

Taichi Sugiyama1, Kayo Ueda2, Xerxes Tesoro Seposo3, Ayako Nakashima4, Makoto Kinoshita4, Hiroko Matsumoto4, Fumikazu Ikemori5, Akiko Honda6, Hirohisa Takano6, Takehiro Michikawa7, Hiroshi Nitta8.   

Abstract

Exposure to fine particulate matter (PM2.5) is a potential aggravating factor for respiratory and allergic diseases. However, which PM2.5 sources are associated with such diseases remains unclear. This study aimed to investigate the association of PM2.5 sources with allergic and respiratory symptoms in schoolchildren. PM2.5 samples were collected in Fukuoka during the spring in 2014 and 2015. Asian dust was observed in 2014. Ion components, elemental components, and organic components were analyzed. Positive matrix factorization (PMF) was conducted to calculate PM2.5 concentrations from each source. Mixed logistic regression analysis with a random intercept for each schoolchild was performed to evaluate the association of components and sources with symptoms. Among 2317 schoolchildren, the mean prevalence was 28.9%, 23.6%, 11.2%, and 11.4% for lower respiratory, nasal, ocular, and skin symptoms, respectively. PMF identified the following six PM2.5 sources "Secondary sulfate and coal combustion", "Secondary nitrate", "Heavy oil combustion", "Sea salt", "Soil" and "Traffic emission". An interquartile range of PM2.5 mass was associated with nasal (Odds ratios 1.08, 95% confidence interval [1.03, 1.13]), ocular (1.10, [1.04, 1.16]), and skin symptoms (1.13, [1.06, 1.20]). Among the source factors, "Heavy oil combustion" was significantly associated with nasal symptom (1.11, [1.05, 1.18]) while "Sea salt" was associated with nasal (1.06, [1.02, 1.11]) and skin (1.073, [1.01, 1.14]) symptoms. We found "Soil", which might be affected by Asian dust, was associated with ocular (1.07, [1.03, 1.10]) and skin (1.05, [1.01, 1.08]) symptoms. Further studies in other seasons or places are needed to clarify the influence of PM2.5 sources on children's health.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Air pollution; Health effects; PM(2.5); Source apportionment

Mesh:

Substances:

Year:  2019        PMID: 31884280     DOI: 10.1016/j.scitotenv.2019.136023

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Impacts of exposure to air pollution, radon and climate drivers on the COVID-19 pandemic in Bucharest, Romania: A time series study.

Authors:  Maria A Zoran; Roxana S Savastru; Dan M Savastru; Marina N Tautan
Journal:  Environ Res       Date:  2022-05-18       Impact factor: 8.431

2.  The Impact of Particulate Matter (PM2.5) on Human Retinal Development in hESC-Derived Retinal Organoids.

Authors:  Yuxiao Zeng; Minghui Li; Ting Zou; Xi Chen; Qiyou Li; Yijian Li; Lingling Ge; Siyu Chen; Haiwei Xu
Journal:  Front Cell Dev Biol       Date:  2021-02-12

3.  Cumulative effects of air pollution and climate drivers on COVID-19 multiwaves in Bucharest, Romania.

Authors:  Maria A Zoran; Roxana S Savastru; Dan M Savastru; Marina N Tautan
Journal:  Process Saf Environ Prot       Date:  2022-08-20       Impact factor: 7.926

4.  Environmental and Air Pollution Factors Affecting Allergic Eye Disease in Children and Adolescents in India.

Authors:  Anthony Vipin Das; Sayan Basu
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

5.  Assessing the impact of air pollution and climate seasonality on COVID-19 multiwaves in Madrid, Spain.

Authors:  Maria A Zoran; Roxana S Savastru; Dan M Savastru; Marina N Tautan; Laurentiu A Baschir; Daniel V Tenciu
Journal:  Environ Res       Date:  2021-08-06       Impact factor: 8.431

6.  Fine Particulate Matter (PM2.5) upregulates expression of Inflammasome NLRP1 via ROS/NF-κB signaling in HaCaT Cells.

Authors:  Liu Dong; Ruiming Hu; Dandan Yang; Jinzhuo Zhao; Haidong Kan; Jianguo Tan; Ming Guan; Zhihua Kang; Feng Xu
Journal:  Int J Med Sci       Date:  2020-09-01       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.